Byetta injection just once a week?
This just in: Amylin has started a clinical trial for Exenatide LAR (Long-Acting Release) drug for type 2 diabetics. Safety and efficacy is being studied so that they have data to present for a New Drug Application to the FDA.
The study will involve 300 type 2 diabetics, split into two groups. One group gets the Exenatide LAR, the other gets the standard 10mcg dose of Byetta. Efficacy will be determined after 30 weeks of trials.
If all goes well, soon Byetta will only need to be taken once a week!
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment